# US 2025/0017978 A1 · Traditional chinese medicine composition and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0017978 A1
- Document ID: US20250017978A1
- Status: Published application
- Kind: A1
- Application number: 18/715,154
- Filed: 2022-09-13
- Published: 2025-01-16
- Earliest claimed: 2021-12-02
- Assignees: Jiangsu Kanion Pharmaceutical Co., Ltd.
- Applicants: Jiangsu Kanion Pharmaceutical Co., Ltd
- Inventors: Wei XIAO; Haibo LI; Guiping LI; Tuanjie WANG; Shasha GU; Xu LI; Quanchang ZHANG; Liang CAO; Wenjun LIU; Chenfeng ZHANG; Zhenzhong WANG
- Web page: https://patentgrep.com/patent/US20250017978A1

## CPC

- A61K 35/413: Gall bladder; Bile
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/575: substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A61K 31/704: attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)}
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61K 36/484: Glycyrrhiza (licorice)
- A61K 36/539: Scutellaria (skullcap)
- A61K 36/708: Rheum (rhubarb)
- A61K 36/8966: Fritillaria, e.g. checker lily or mission bells
- A61P 11/14: Antitussive agents
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/14: for RNA viruses
- A61K 2236/331: using water, e.g. cold water, infusion, tea, steam distillation or decoction
- A61K 2236/51: Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
- A61K 2236/53: Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The disclosure relates to a traditional Chinese medicine composition, comprising active ingredients derived from Cornu caprae or Cornu saigae tataricae, Radix scutellariae, Bulbus fritillariae ussuriensis, Radix glycyrrhizae, Radix et rhizoma rhei, Gypsum fibrosum, Calculus bovis artifactus and Lapis Chloriti, the said active ingredients comprise in parts by weight: at least 1600 parts of amino acids; at least 120 parts of gallic acid; at least 130 parts of liquiritin; at least 20 parts of liquiritigenin; at least 400 parts of baicalin; at least 40 parts of oroxyloside; at least 120 parts of wogonoside; at least 280 parts of glycyrrhizic acid; at least 12 parts of chrysin-7-O-β-D-glucoronic acid; at least 50 parts of aloe-emodin-8-O-β-D-glucopyranoside; at least 30 parts of chrysophanol-1-O-β-D-glucopyranoside; at least 45 parts of chrysophanol-8-O-β-D-glucopyranoside; at least 260 parts of hyodeoxycholic acid; at least 150 parts of cholic acid. The traditional Chinese medicine composition in the present invention possess antipyretic, anti-inflammatory and antitussive effects.

## Claims

### Claim 1

A traditional Chinese medicine composition, containing active ingredients derived from the following traditional Chinese medicines: Cornu caprae or Cornu saigae tataricae, Radix scutellariae, Bulbus fritillariae ussuriensis, Radix glycyrrhizae, Radix et Rhizoma rhei, Gypsum fibrosum, Calculus bovis artifactus, and Lapis Chloriti, wherein the active ingredients comprise by weight: at least 1600 parts of amino acids, at least 120 parts of gallic acid, at least 130 parts of liquiritin, at least 20 parts of liquiritigenin, at least 400 parts of baicalin, at least 40 parts of oroxyloside, at least 120 parts of wogonoside, at least 280 parts of glycyrrhizic acid, at least 12 parts of chrysin-7-O-β-D-glucoronic acid, at least 50 parts of aloe-emodin 8-O-β-D-glucopyranoside, at least 30 parts of chrysophanol-1-O-β-D-glucopyranoside, at least 45 parts of chrysophanol-8-O-β-D-glucopyranoside, at least 260 parts of hyodeoxycholic acid, at least 150 parts of cholic acid.

### Claim 2 (depends on 1)

The traditional Chinese medicine composition according to claim 1, wherein the active ingredients comprise: 1610.45-1901.21 parts of amino acids, 120.27-167.01 parts of gallic acid, 136.22-172.23 parts of liquiritin, 21.23-37.12 parts of liquiritigenin, 411.30-542.50 parts of baicalin, 40.54-55.01 parts of oroxyloside, 121.11-148.22 parts of wogonoside, 287.88-333.32 parts of glycyrrhizic acid, 12.87-24.11 parts of chrysin-7-O-β-D-glucoronic acid, 50.11-55.21 parts of aloe-emodin 8-O-β-D-glucopyranoside, 30.71-38.56 parts of chrysophanol-1-O-β-D-glucopyranoside, 45.09-57.88 parts of chrysophanol-8-O-β-D-glucopyranoside, 260.11-285.32 parts of hyodeoxycholic acid, 151.11-191.03 parts of cholic acid.

### Claim 3 (depends on 2)

The traditional Chinese medicine composition according to claim 2, wherein the medicine is in any clinically acceptable dosage form.

### Claim 4 (depends on 3)

The traditional Chinese medicine composition according to claim 3, wherein the dosage form is any one of decoction, granule, capsule, soft capsule, pill, oral liquid, tincture, syrup, suppository, gel, spray and injection.

### Claim 5 (depends on 2)

A method for preparing the Chinese medicine composition of claim 2, wherein the method comprises the following steps:
taking 18.9 parts of Cornu caprae or 1.89 parts of Cornu saigae tataricae, 9.45 parts of Bulbus fritillariae ussuriensis, 6.3 parts of Radix et Rhizoma rhei, 3.15 parts of radix scutellariae, 3.15 parts of Lapis Chloriti, 4.724 parts of Gypsum fibrosum, 1.89 parts of Calculus bovis artifactus and 6.3 parts of Radix glycyrrhizae;
crushing the Cornu caprae or Cornu saigae tataricae into fine powder;
hydrolyzing the powder with a sodium hydroxide-containing aqueous solution, filtering, and concentrating the filtrate;
crushing the Lapis Chloriti and Gympsum fibrosum into crude powder;
heating and decocting the crushed Lapis Chloriti and Gympsum fibrosum in water, filtering, and concentrating the filtrate;
extracting the Calculus bovis artifactus with ethanol reflux, filtering, and concentrating the filtrate;
decocting a rest of medicine in water, filtering, concentrating the filtrate and centrifuging, adding ethanol to the supernatant to precipitate; standing, taking the supernatant, filtering, recovering the ethanol under reduced pressure, concentrating, and combining the concentrated filtrate obtained above.

### Claim 6 (depends on 5)

The preparation method according to claim 5, wherein the traditional Chinese medicine is in the form of an oral liquid, the preparation method comprises:
uniformly mixing the mixed concentrated filtrate with 0.2% steviosin, adding water to make up to 1000 ml, uniformly mixing, boiling for 40 minutes, refrigerating for not less than 48 h, filtering, adding water into the filtrate to make up to 1000 ml, adjusting the pH of the filtrate to be 8.0-9.0, filling and sterilizing, wherein Cornu caprae 94.5 g or cornu saigae tataricae 9.45 g, Bulbus fritillariae ussuriensis 47.25 g, Radix et Rhizoma rhei 31.50 g, Radix scutellariae 15.75 g, Lapis Chloriti 15.75 g, Gypsum fibrosum 23.62 g, Calculus bovis artifactus 9.45 g and Radix glycyrrhizae 31.45 g.

### Claim 7 (depends on 2)

Use of the traditional Chinese medicine composition according to claim 2, wherein the traditional Chinese medicine composition is used for antipyretic, inflammatory, antitussive and/or anti-novel coronavirus.

### Claim 8 (depends on 2)

A method for detecting the active ingredients of the traditional Chinese medicine composition according to claim 2, characterized by conducting HPLC detection, wherein the chromatographic conditions comprise: COSMOSIL-C18 chromatographic column with specifications of 4.6 mm×250 mm, 5.0 μm; mobile phase: methanol (B)—aqueous acid (A) (containing 0.1% formic acid), gradient elution: 0-15 min: 10-40% B, 15-70 min: 40-70% B, 70-90 min: 70-100% B; flow rate 0.8-1.2 mL/min, column temperature 30-40° C.

### Claim 9

(canceled)
